Published in Immunol Lett on August 03, 1999
Hairpin ribozyme-antisense RNA constructs can act as molecular Lassos. Nucleic Acids Res (2008) 0.75
Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine (2000) 2.25
Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett (2001) 2.15
Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett (1987) 1.62
[Interleukin-6: friend or enemy? Latest findings on the clinical aspects of IL-6]. Orv Hetil (1994) 1.49
Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res (2009) 1.34
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol (2001) 1.29
Interleukin 6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production. J Rheumatol (1992) 1.25
Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus. Neuroscience (2001) 1.17
Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res (1999) 1.12
Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific. J Immunol (1987) 1.09
IgE and IgE-rheumatoid factors in circulating immune complexes in rheumatoid arthritis. Ann Rheum Dis (1982) 1.09
Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand J Gastroenterol Suppl (1998) 1.09
Radioimmune double PEG precipitation technique for detecting complexed IgE. J Immunol Methods (1979) 1.06
Mouse plasmacytoma: an experimental model of human multiple myeloma. Haematologica (2001) 1.06
Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma. Cell Biol Int (2000) 1.06
Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection (2005) 1.05
CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol (2001) 1.00
New developments in septic acute kidney injury. Physiol Res (2010) 0.98
Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody. J Immunol Methods (1998) 0.98
IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes. Ann Rheum Dis (1984) 0.97
Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm Res (2001) 0.97
The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med (1987) 0.96
Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. Diagn Microbiol Infect Dis (1999) 0.94
Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis (1980) 0.93
Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) (2003) 0.93
Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed. Oncogene (2010) 0.92
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers. Inflamm Res (2003) 0.92
Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett (2000) 0.92
Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study. J Immunol Methods (1980) 0.92
Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy (2005) 0.91
The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol (1996) 0.91
Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci U S A (2003) 0.90
The effect of heparin rinse on the biocompatibility of continuous veno-venous hemodiafiltration. Int J Artif Organs (2002) 0.90
Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. Immunol Lett (2000) 0.89
Asthma from a pharmacogenomic point of view. Br J Pharmacol (2008) 0.89
Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J Neuropathol Exp Neurol (2001) 0.88
Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia. Intensive Care Med (1998) 0.88
DNA polymorphism of MHC III genes in inbred and wild mouse strains. Immunogenetics (1987) 0.87
Human beta 2-microglobulin is a substrate of tissue transglutaminase: polymerization in solution and on the cell surface. J Cell Biol (1981) 0.87
Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. Pharmacogenomics J (2008) 0.86
The significance of the circumaortic left renal vein and other venous variations in laparoscopic living donor nephrectomies. Transplant Proc (2011) 0.85
T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta (2008) 0.85
The radiotherapy of cystic craniopharyngioma with intracystic installation of 90Y silicate colloid. Acta Neurochir (Wien) (1985) 0.84
Beta2-microglobulin-containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients. Scand J Immunol (1981) 0.84
Cholinergic signals to and from the immune system. Immunol Lett (1995) 0.83
Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions (1991) 0.83
Histidine decarboxylase expression in human melanoma. J Invest Dermatol (2000) 0.83
Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet (2000) 0.83
Central neurocytoma with malignant course. Neuronal and glial differentiation and craniospinal dissemination. Pathol Oncol Res (1999) 0.83
Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)-1 beta, IL-6 and tumour necrosis factor (TNF)-alpha. Scand J Immunol (1993) 0.83
Some aspects of interindividual variations in the metabolism of xenobiotics. Inflamm Res (2003) 0.82
[24-year old male with fever, multi-organ dysfunction and fast progressing ARDS]. Vnitr Lek (2009) 0.82
Different interferon-inducing ability of human adenovirus types in chick embryo cells. Acta Virol (1983) 0.82
Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett (2001) 0.82
Cytokine regulation of the acute-phase protein levels in multiple myeloma. Eur J Clin Invest (1998) 0.82
Cellular autophagic capacity is highly increased in azaserine-induced premalignant atypical acinar nodule cells. Carcinogenesis (1999) 0.82
Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Semin Cancer Biol (2000) 0.82
Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine (1998) 0.81
Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Med Sci Monit (2001) 0.81
Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Invest Dermatol (2001) 0.81
Effect of voluntary innervation on the evoked potential of the motor system. Confin Neurol (1975) 0.81
Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. J Immunol Methods (1981) 0.81
Microencapsulation technology by nature: Cell derived extracellular vesicles with therapeutic potential. Eur J Microbiol Immunol (Bp) (2013) 0.81
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin Cancer Biol (2000) 0.81
The role of the cortex and subcortical ganglia in the evoked rhythmic motor activity. Acta Neurochir (Wien) (1974) 0.81
[On the active materials of Dictamuus albus L. 1. Photodynamic materials]. Pharmazie (1968) 0.81
Continuous venovenous hemofiltration: effects on monocyte and lymphocyte immunophenotype in critically ill patients. Int J Artif Organs (2002) 0.81
Autoantibodies specific to beta-2-microglobulin inhibit the Fc receptor-dependent phagocytosis of human monocytes. Immunol Lett (1981) 0.81
Complexed rheumatoid factor measurements in sera, synovial fluids and in immune complex fractions. Experientia (1979) 0.80
Preparation of local Shwartzman reaction by means of platelet rich plasma. Acta Physiol Acad Sci Hung (1972) 0.80
Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro. Cell Biol Int (2000) 0.80
Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages. Immunology (1987) 0.80
The study of recovery and modification of the evoked potentials and motor answers in the motor system. Acta Neurochir (Wien) (1977) 0.80
Prevalence of anti-beta-2 microglobulin autoantibodies in sera of rheumatoid arthritis patients with extra-articular manifestations. Ann Rheum Dis (1981) 0.80
The effect of exercise and oxidant-antioxidant intervention on the levels of neurotrophins and free radicals in spinal cord of rats. Spinal Cord (2008) 0.80
Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur J Clin Invest (2002) 0.80
Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors. Cell Biol Int (2001) 0.80
Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol (2001) 0.80
[Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis]. Orv Hetil (1985) 0.80
Histamine as a potential autocrine regulator of melanoma. Inflamm Res (2001) 0.80
Appearance of covalently bound antigen in immune complexes formed during the activation of complement. J Immunol Methods (1984) 0.80
Opposite effect of linearly polarized light on biosynthesis of interleukin-6 in a human B lymphoid cell line and peripheral human monocytes. Cell Biol Int (2002) 0.79
Enteral nutrition and hepatosplanchnic region in critically ill patients - friends or foes? Physiol Res (2003) 0.79
Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood-brain barrier permeability in the rat. Eur J Pharmacol (2000) 0.79
Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation. Inflamm Res (2001) 0.79
Use of porous pyrolytic carbon for analytical and microscale high-performance liquid chromatographic bioseparations. J Chromatogr B Biomed Sci Appl (1998) 0.79
Effect of H1 and H2 agonists on the chemiluminescence of human blood mononuclear cells induced by phytohaemagglutinin. Immunopharmacology (1985) 0.79
Specific antibody-fragments against the postsynaptic web. Nat New Biol (1973) 0.79
HCV antibodies in Hungarian blood donations. Experiences collected by ELISA tests, immunoblot assays and polymerase chain reaction and protocols for donor management. Transfus Med (1994) 0.79
Exon-intron organization of the human gp130 gene. Gene (2000) 0.79
Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation. Clin Exp Immunol (1982) 0.79
Partial characterization of circulating macromolecular beta 2-microglobulin complexes by density gradient ultracentrifugation and page-blotting. Immunol Lett (1983) 0.79
[Fluid resuscitation in conditions with disorders of capillary permeability]. Cas Lek Cesk (2002) 0.79